250mg Geftinat Gefitinib Tablets

250mg Geftinat Gefitinib Tablets Specification

Indication
Pancreatic cancer treatment

Dosage Form
Tablet

Salt Composition
Gefitinib

Feature
Targeted therapy, EGFR inhibitor

Application
Oral anti-cancer therapy

Physical Color/Texture
White to off-white tablet

Fermentation Smell
Odorless

Storage Instructions
Store below 30C, dry place

Shelf Life
24 months

Administration Route
Oral

Packaging Type
Box

Prescription Type
Prescription only

Patient Group
Adults

Pack Size
30 tablets

Tablet Shape
Round

Tablet Marking
Imprinted

Dose/Strength
250 mg

250mg Geftinat Gefitinib Tablets Trade Information

Minimum Order Quantity
5000 Bottles

Supply Ability
100 Bottles Per Day

Delivery Time
3-4 Days

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About 250mg Geftinat Gefitinib Tablets

Discover the Best-seller 250mg Geftinat Gefitinib Tablets, a Must-have oral anti-cancer therapy remarked for its uncommon efficacy in treating pancreatic cancer. This First-string prescription medication features a targeted EGFR inhibitor formula, delivering 250mg Gefitinib per round, imprinted tablet. With a pack size of 30 tablets, each white to off-white tablet is odorless and designed for adults. Securely packaged in a box, this hot deal offers a remarkable treatment route with a 24-month shelf life. Geftinat is trusted by exporters, suppliers, and traders across India for optimal patient care.

Competitive Edge & Applications Beyond Pancreatic Cancer

250mg Geftinat Gefitinib Tablets offer unparalleled value not just as a frontline anti-cancer therapy for pancreatic cancer, but also in treating select other EGFR-positive malignancies, pending medical guidance. Benefiting from superior targeting, these tablets maximize tumor inhibition while limiting systemic side effects-a competitive advantage. Their formulation ensures consistent results, making them an advantageous choice for oncologists and adult patients requiring an uncommon, effective targeted therapy in cancer management.

Supply, Delivery & Seamless Domestic Transportation

With a robust supply ability, 250mg Geftinat Gefitinib Tablets are available to meet steady domestic market demand. Shipped goods are handled via secure transportation channels, ensuring timely and intact delivery. Most orders are processed promptly, with reliable delivery times in line with industry standards. Our sample policy accommodates healthcare professionals seeking product assurance before large-scale procurement, illustrating our commitment to quality and service in the Indian pharmaceutical sector.

FAQ's of 250mg Geftinat Gefitinib Tablets:

Q: How should 250mg Geftinat Gefitinib Tablets be taken?

A: These tablets are administered orally, once daily or as prescribed by your oncologist, and should be swallowed whole with water.

Q: What makes Geftinat Gefitinib Tablets a must-have in cancer therapy?

A: Geftinat stands out for its targeted approach as an EGFR inhibitor, providing effective tumor suppression with reduced side effects compared to traditional chemotherapy.

Q: When can patients expect to see results from Geftinat Gefitinib therapy?

A: Results vary depending on the individual and cancer stage, but most patients may notice clinical improvements after some weeks of continuous, prescribed use.